Topic
AI Capex Research
Current research indicates that AI infrastructure demand remains a primary driver for equity market strength, contributing significantly to a 26% year-over-year earnings growth in Q1 2026. This momentum has prompted revisions to market targets, with the S&P 500 projected to reach 8,000, supported by software gains and hardware innovations like Nvidia’s RTX Spark chip. Beyond mega-cap tech, AI-related capital expenditure is fostering a turnaround in small-cap equities and driving renewed M&A activity within the sector. The capital commitment to this space is further highlighted by high-profile moves such as Anthropic’s IPO filing, even as broader markets face headwinds from sticky inflation and headline PCE at 3.8%. Despite these macroeconomic pressures and rising energy costs, institutional flows remain concentrated in US large-cap products that capture AI growth. Ultimately, the research suggests that while inflationary risks persist, the secular trend of AI capex continues to underpin global equity sentiment and valuation expansions.
4307 reports available
All reports
Page 71 of 180
US Oil Rig Count Trends
Barclays · Jun 9, 2026
USA Economic Indicators Update
Goldman Sachs · Jun 9, 2026
DBDaily
Deutsche Bank · Jun 9, 2026
Daily Europe
UBS · Jun 9, 2026
GS Basics - Token Expenditure Apple Monetization Debate
Goldman Sachs · Jun 9, 2026
Micron Technology Inc. 3Q Preview
Goldman Sachs · Jun 9, 2026
AI Volatility Is Back But The Capex Story Still Looks Firm
UBS · Jun 9, 2026
Early Morning Reid
Deutsche Bank · Jun 9, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · Jun 9, 2026
The 720 Japan Tech China Internet And Corporate Strategy Updates
Goldman Sachs · Jun 9, 2026
GS Sustain: The Reliability Imperative
Goldman Sachs · Jun 9, 2026
European Equity Factor Insights
Barclays · Jun 9, 2026
Multi-Asset Strategy Daily
Mizuho International · Jun 9, 2026
Investing in Brazil
UBS · Jun 9, 2026
Global Macro Monthly
TS Lombard · Jun 9, 2026
Apple Another AI Attempt At WWDC
Barclays · Jun 9, 2026
Sino Biopharmaceutical Key Takeaways
Goldman Sachs · Jun 9, 2026
Teva Pharmaceuticals Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
Health Care Offers More Than a Defensive Role in Portfolios
UBS · Jun 9, 2026
Turkiye Banks Sector Trends
Goldman Sachs · Jun 9, 2026
US Equities Color Broadening
Goldman Sachs & Co. LLC · Jun 9, 2026
Seaport Therapeutics Additional Phase 1 Data Validates the Glyph Platform
Goldman Sachs · Jun 9, 2026
EU Energy Sector Specialist Commentary
J.P. Morgan · Jun 9, 2026
The Point For Europe
Citi · Jun 9, 2026